Learn more about the CPDC-adMare Radiopharmaceutical Initiative (CARI)

You’re Cordially Invited To A Webinar

Learn more about the CPDC-adMare Radiopharmaceutical Initiative (CARI)

If you are an academic researcher or a biotech company looking to pave the road to successful commercialization of your radiopharmaceutical innovation, join us on October 15th, 2020.

What is CARI?

CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInovations (adMare) where we will bring respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain considerable global competitive advantage: RADIOPHARMACEUTICALS. The objective of CARI, is for CPDC and adMare to seek out and uncover radiopharmaceutical opportunities arising from academic discoveries and early enterprises, establish rigorous drug development programs around selected opportunities, and drive the generation of proof-of-principle and other data supportive of the commercialization of new radiopharmaceutical assets.

Have More Questions About CARI? Then You Don’t Want To Miss This Webinar!

Please kindly register before Wednesday, Oct. 14th – click here to register.